Executive Summary
Key Takeaways
- Terminate compounded GLP-1 sales to avoid DOJ investigations: Hims & Hers ceased selling unapproved versions after HHS and the FDA threatened decisive enforcement actions against mass-marketed obesity medications. Source
- Audit Medicaid enrollees' work status by Q2 2026: Nebraska will begin work requirements on May 1, 2026, impacting 72,000 enrollees who must prove 80 hours of monthly activity. Source
- Prepare for lower emergency care volume among immigrant populations: ICE now has access to Medicaid data in 28 states, including home addresses, to target Emergency Medicaid users. Source
- Utilize generic alternatives over the TrumpRx platform: While the administration's site offers cash discounts on 43 brand-name drugs, existing generics on Mark Cuban’s Cost Plus Drugs are often cheaper. Source
Key Themes
Major trends and developments identified from this week's coverage
GLP-1 Enforcement Crackdown
Federal agencies are leveraging all available enforcement tools to restrict the production and marketing of unapproved compounded GLP-1 medications.
Health Data Interoperability Expansion
The ONC and ASTP are dismantling health data silos by targeting diagnostic imaging interoperability and pushing for FHIR-based patient access.
Supply Chain Security Modernization
The FDA is streamlining both import reviews and domestic facility assessments to strengthen the pharmaceutical supply chain against counterfeit and contaminated products.
3 articles
Supporting Articles
- FDA ImportShield Program Delivers Impressive Results in Strengthening FDA Oversight at U.S. Ports of Entry | FDA
- FDA Launches PreCheck Pilot Program to Strengthen Domestic Pharmaceutical Manufacturing | FDA
- With ICE Using Medicaid Data, Hospitals and States Are in a Bind Over Warning Immigrant Patients
Key Players
Top companies, people, and technologies mentioned this week
7 articles
Signed government spending legislation providing for HHS and Medicare programs. (+6 more)
6 articles
The HHS Secretary who has criticized the VICP as 'broken' and appointed Andrew Downing as an adviser. (+5 more)
6 articles
Stated it would take decisive steps against companies mass-marketing unapproved compounded GLP-1 drugs. (+5 more)
6 articles
The organization producing the health policy news podcast. (+5 more)
4 articles
The executive branch responsible for the crackdown on homeless encampments in the nation's capital. (+3 more)
3 articles
The agency issued a letter to industry regarding enforcement discretion for 'no artificial colors' claims. (+2 more)
2 articles
The federal agency overseeing Medicare and Medicaid services. (+1 more)
2 articles
Administrator of the Centers for Medicare and Medicaid Services (CMS) who accused California of manipulating federal funds. (+1 more)
4 articles
FDA Commissioner who noted that calling natural colors 'artificial' was confusing for consumers. (+1 more)
2 articles
Centers for Disease Control and Prevention, which was directed to stop recommending vaccines for certain groups. (+1 more)
Regulatory & Policy Updates
FDA launches PreCheck pilot program for domestic drug manufacturing
Manufacturers can receive early technical advice and pre-operational reviews to expedite facility assessments before filing product applications.
CMS/MEDICARENebraska scheduled early Medicaid work requirements for May 2026
State officials will use automated data matching to verify enrollees' work status, aiming to avoid increasing administrative staffing.
FDAFDA ImportShield Program increased processing speed by 66%
Consolidated regional teams now provide centralized oversight and real-time alerts on counterfeit medications at all U.S. ports of entry.
FDAFDA increased disclosure requirements for gluten in food products
Food manufacturers must comply with new labeling standards to improve transparency for consumers with celiac disease or gluten sensitivities.
Technology & Innovation
ASTP/ONC released RFI to optimize diagnostic imaging exchange
Future regulations will likely target the "CD and DVD" era of image sharing by mandating seamless Care Team movement of high-resolution diagnostic files.
Hospitals reached 99% electronic health info access for patients
While core digitization is nearly universal, only 56% of hospitals can currently import external records, marking the next competitive frontier in patient engagement.
EHR vendors restrict "write" access to protect business logic layer IP
Interoperability progress remains stalled at the application logic layer, as vendors treat state machines and business rules as critical intellectual property.
Market & Competitive Intelligence
Hims & Hers
PartnershipHims & Hers withdrew its $49 compounded obesity pill following HHS and DOJ warnings of potential federal law violations.
TrumpRx
Market EntryThe Trump administration's TrumpRx platform competes with Mark Cuban’s Cost Plus Drugs and GoodRx for cash-paying customers seeking brand-name discounts.
Upswing Health
PartnershipUpswing Health is positioning digital triage tools to help self-insured employers divert low-acuity musculoskeletal injuries away from high-cost emergency rooms.
What to Watch
Diagnostic Imaging Interoperability Rules
Next 45 days for comments; 2026 for potential rulesThe ASTP/ONC diagnostic imaging RFI closes in 45 days. Executives should monitor for subsequent rulemaking that could mandate FHIR-based image exchange across disparate health systems.
DOJ/FDA Compounding Investigations
H1 2026Following the Hims & Hers retreat, watch for a broader wave of FDA seizures and DOJ investigations targeting other telehealth companies still marketing compounded GLP-1s.
Medicaid Work Requirement Rollout
May 1, 2026Nebraska’s May 2026 Medicaid work requirement launch will serve as the pilot for federal implementation. Monitor for "procedural disenrollment" rates as a metric for success or failure.
Editor's Picks
AI-recommended articles based on relevance and quality
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Center for Scientific Review; Notice of Closed Meetings
Center for Scientific Review; Amended Notice of Meeting
Center for Scientific Review; Notice of Closed Meetings
National Heart, Lung, and Blood Institute; Amended Notice of Meeting
Want personalized briefings?
Kelp creates AI-powered briefings tailored to your specific interests and sources. Get the insights that matter most to you.
Start Your Free Briefing